Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11 PLN | 0.00% | 0.00% | +27.17% |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 129.4 | 91.67 | 142 | 250.7 | 451.8 | 451.8 |
Enterprise Value (EV) 1 | 203.9 | 188.5 | 257.8 | 312.6 | 525.4 | 525.5 |
P/E ratio | 173 x | -5.76 x | -10.2 x | -32.6 x | 94.2 x | -272 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.42 x | 0.27 x | 0.35 x | 0.57 x | 0.88 x | 0.79 x |
EV / Revenue | 0.65 x | 0.56 x | 0.63 x | 0.71 x | 1.02 x | 0.91 x |
EV / EBITDA | 13.3 x | 26.1 x | 18 x | 20.2 x | 20 x | 21.5 x |
EV / FCF | 745 x | -26 x | 23.7 x | -254 x | -90.7 x | 84.4 x |
FCF Yield | 0.13% | -3.84% | 4.22% | -0.39% | -1.1% | 1.18% |
Price to Book | 1.05 x | 0.87 x | 1.3 x | 1.4 x | 2.49 x | 2.5 x |
Nbr of stocks (in thousands) | 13,285 | 13,285 | 22,189 | 22,189 | 41,447 | 41,447 |
Reference price 2 | 9.740 | 6.900 | 6.400 | 11.30 | 10.90 | 10.90 |
Announcement Date | 3/16/18 | 4/16/19 | 3/31/20 | 4/1/21 | 3/31/22 | 3/27/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 311.5 | 337.8 | 410.4 | 441.4 | 514.8 | 575.1 |
EBITDA 1 | 15.34 | 7.214 | 14.34 | 15.46 | 26.27 | 24.47 |
EBIT 1 | 1.434 | -7.657 | -0.093 | 2.24 | 8.445 | 5.046 |
Operating Margin | 0.46% | -2.27% | -0.02% | 0.51% | 1.64% | 0.88% |
Earnings before Tax (EBT) 1 | -0.042 | -15.7 | -7.399 | -5.156 | 6.435 | -0.243 |
Net income 1 | 0.747 | -15.91 | -8.465 | -7.702 | 2.629 | -1.659 |
Net margin | 0.24% | -4.71% | -2.06% | -1.75% | 0.51% | -0.29% |
EPS 2 | 0.0562 | -1.197 | -0.6279 | -0.3471 | 0.1157 | -0.0400 |
Free Cash Flow 1 | 0.2736 | -7.239 | 10.88 | -1.229 | -5.791 | 6.227 |
FCF margin | 0.09% | -2.14% | 2.65% | -0.28% | -1.12% | 1.08% |
FCF Conversion (EBITDA) | 1.78% | - | 75.88% | - | - | 25.45% |
FCF Conversion (Net income) | 36.63% | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/16/18 | 4/16/19 | 3/31/20 | 4/1/21 | 3/31/22 | 3/27/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 74.5 | 96.8 | 116 | 61.9 | 73.7 | 73.8 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 4.854 x | 13.42 x | 8.074 x | 4.002 x | 2.805 x | 3.014 x |
Free Cash Flow 1 | 0.27 | -7.24 | 10.9 | -1.23 | -5.79 | 6.23 |
ROE (net income / shareholders' equity) | -1.1% | -13.8% | -8.27% | -4.77% | 1.93% | -0.8% |
ROA (Net income/ Total Assets) | 0.32% | -1.65% | -0.02% | 0.37% | 1.37% | 0.77% |
Assets 1 | 236.6 | 964.4 | 48,371 | -2,066 | 191.7 | -215.3 |
Book Value Per Share 2 | 9.270 | 7.970 | 4.930 | 8.050 | 4.370 | 4.360 |
Cash Flow per Share 2 | 0.8800 | 0.6000 | 1.100 | 1.030 | 0.1900 | 0.8400 |
Capex 1 | 22.9 | 8.45 | 12 | 27.8 | 27.7 | 34.7 |
Capex / Sales | 7.34% | 2.5% | 2.91% | 6.3% | 5.38% | 6.03% |
Announcement Date | 3/16/18 | 4/16/19 | 3/31/20 | 4/1/21 | 3/31/22 | 3/27/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+27.17% | 114M | |
-20.16% | 16.21B | |
+4.50% | 12.44B | |
+3.98% | 11.58B | |
+5.25% | 10.79B | |
-0.21% | 7.68B | |
+18.43% | 7.06B | |
+4.49% | 6.67B | |
+50.89% | 4.66B | |
-5.12% | 4.25B |
- Stock Market
- Equities
- EMC Stock
- Financials EMC Instytut Medyczny SA